Nature Medicine, Published online: 10 February 2025; doi:10.1038/s41591-024-03400-0
Two new phosphorylation sites, p-tau262 and p-tau356, detect the formation of prefibrillar tau aggregates and may serve as early-stage biofluid-based biomarkers of tau neurofibrillary tangle pathology in Alzheimer’s disease.
